Skip to content

Intervention and efficacy evaluation study of Uncut Roux-en-Y Hepatoportoenterostomy in Pediatric Genneral Surgery

Intervention and efficacy evaluation study of Uncut Roux-en-Y Hepatoportoenterostomy in Pediatric Genneral Surgery

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-09000326
Enrollment
Unknown
Registered
2009-02-11
Start date
2008-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the disease of biliary tract in children

Interventions

A group:Without Uncut Roux-en-Y Hepatoportoenterostomy
B group:With Uncut Roux-en-Y Hepatoportoenterostomy

Sponsors

The First Affiliated Hospital of Sun Yat Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. infants with pathologic jaundice; 2. increased levels of serum bilirubi; 3. through the ultrasonography, the patients suspected with biliary atresia or cholangiectasis; 4. Patient can tolerate general anesthesia; 5.Informed consents and willing to participant; signed the informed consent form accords with ethics principles.

Exclusion criteria

Exclusion criteria: 1. For the C level liver function according to "child classification" or biliary cirrhosis,the patients with BA underwent exploratory laparotomy and liver biopsy instead Uncut Roux-en-Y Hepatoportoenterostomy; 2. For inflammation, jaundice, biliary perforation, the patients with cholangiectasis underwent internal or external drainage; 3. severe complications threaten the patients' life; 4. the patients and their family reject.

Design outcomes

Primary

MeasureTime frame
ratio of early cholangiolitis;persistence time of cholangiolitis and the highest temperature, the value of serum WBC, neutrophilic;the time of using antibiotics ang the work time;

Secondary

MeasureTime frame
bacterial culture and drug sensitive of blood, when the patients suffered cholangiolitis;

Countries

China

Contacts

Public ContactLiu Juncheng
liujcgd@tom.com+86 0 13543466640

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026